Sarah Alexander

6.0k total citations
125 papers, 3.1k citations indexed

About

Sarah Alexander is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Sarah Alexander has authored 125 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pediatrics, Perinatology and Child Health, 50 papers in Public Health, Environmental and Occupational Health and 42 papers in Oncology. Recurrent topics in Sarah Alexander's work include Childhood Cancer Survivors' Quality of Life (47 papers), Acute Lymphoblastic Leukemia research (34 papers) and Neutropenia and Cancer Infections (21 papers). Sarah Alexander is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (47 papers), Acute Lymphoblastic Leukemia research (34 papers) and Neutropenia and Cancer Infections (21 papers). Sarah Alexander collaborates with scholars based in Canada, United States and United Kingdom. Sarah Alexander's co-authors include Lillian Sung, Joanne Wolfe, Alisha Kassam, Brian T. Fisher, L. Lee Dupuis, Furqan Shaikh, Bob Phillips, Thomas Lehrnbecher, Christopher C. Dvorak and Susan K. Parsons and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Sarah Alexander

118 papers receiving 3.1k citations

Peers

Sarah Alexander
Sarah Alexander
Citations per year, relative to Sarah Alexander Sarah Alexander (= 1×) peers Riccardo Haupt

Countries citing papers authored by Sarah Alexander

Since Specialization
Citations

This map shows the geographic impact of Sarah Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Alexander more than expected).

Fields of papers citing papers by Sarah Alexander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Alexander. The network helps show where Sarah Alexander may publish in the future.

Co-authorship network of co-authors of Sarah Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Alexander. A scholar is included among the top collaborators of Sarah Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Alexander. Sarah Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, Paula D., Angela Punnett, Priya Patel, et al.. (2025). Multi‐Institution Harmonization of Infection Care Pathways for Pediatric Oncology. Pediatric Blood & Cancer. 72(8). e31824–e31824.
2.
3.
Alexander, Sarah, et al.. (2025). Uveal involvement as the presenting sign of recurrence of systemic B-cell lymphoma: a case report and description of biopsy technique. Journal of American Association for Pediatric Ophthalmology and Strabismus. 29(5). 104651–104651. 1 indexed citations
4.
El‐Mallawany, Nader Kim, Sarah Alexander, Mark Fluchel, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphoma. Pediatric Blood & Cancer. 70(S6). e30565–e30565. 8 indexed citations
5.
Elgarten, Caitlin W., John A. Kairalla, Joel Thompson, et al.. (2023). SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731. SHILAP Revista de lepidopterología. 4(3). 745–750. 2 indexed citations
6.
Caniza, Miguela A., Jessica Bate, Sarah Alexander, et al.. (2022). Answers to common questions about COVID‐19 vaccines in children with cancer. Pediatric Blood & Cancer. 69(12). e29985–e29985. 4 indexed citations
7.
Lowe, Eric, Anne F. Reilly, Megan S. Lim, et al.. (2022). Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1. Journal of Clinical Oncology. 41(11). 2043–2053. 25 indexed citations
8.
Beauchemin, Melissa, Sheila Judge Santacroce, Kira Bona, et al.. (2022). Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States. BMC Health Services Research. 22(1). 832–832. 13 indexed citations
9.
McNeer, Jennifer L., Maureen M. O’Brien, Susan R. Rheingold, et al.. (2021). A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732. Blood. 138(Supplement 1). 3398–3398. 8 indexed citations
10.
Desjardins, Léandra, Kelly Hancock, Péter Szatmári, et al.. (2021). Protocol for mapping psychosocial screening to resources in pediatric oncology: a pilot randomized controlled trial. Pilot and Feasibility Studies. 7(1). 143–143. 7 indexed citations
11.
Lowe, Eric, Anne F. Reilly, Megan S. Lim, et al.. (2021). Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Blood. 137(26). 3595–3603. 46 indexed citations
12.
Barrera, Maru, Sarah Alexander, Eshetu G. Atenafu, et al.. (2020). Psychosocial screening and mental health in pediatric cancer: A randomized controlled trial.. Health Psychology. 39(5). 381–390. 16 indexed citations
13.
Desjardins, Léandra, Kelly Hancock, Joanna Chung, et al.. (2019). Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months. Supportive Care in Cancer. 28(4). 1717–1723. 4 indexed citations
14.
Wheaton, Laura & Sarah Alexander. (2019). Pregnancy Screening and Contraceptive Counseling in Young Women with Hodgkin Lymphoma: A Single Center Retrospective Review. Journal of Adolescent and Young Adult Oncology. 8(3). 349–353. 1 indexed citations
15.
Barrera, Maru, et al.. (2018). Perceived benefits of and barriers to psychosocial risk screening in pediatric oncology by health care providers. Pediatric Blood & Cancer. 65(12). e27429–e27429. 17 indexed citations
16.
Pole, Jason D., Paul Gibson, Marie‐Chantal Ethier, et al.. (2017). Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis. British Journal of Cancer. 116(4). 540–545. 19 indexed citations
17.
Alexander, Sarah & Rami Doukky. (2014). Effective Risk Stratification of Patients on the Basis of Myocardial Perfusion SPECT Is Dependent on Appropriate Patient Selection. Current Cardiology Reports. 17(1). 549–549. 6 indexed citations
18.
Kirwan, Caitriona, Bo‐Yee Ngan, William Halliday, Sarah Alexander, & Asim Ali. (2013). Primary conjunctival anaplastic large cell lymphoma in a child. Journal of American Association for Pediatric Ophthalmology and Strabismus. 17(4). 437–439. 3 indexed citations
19.
Pole, Jason D., Shabbir M.H. Alibhai, M.C. Ethier, et al.. (2012). Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals. Annals of Oncology. 24(3). 801–806. 11 indexed citations
20.
Phillips, Bob, Thomas Lehrnbecher, Sarah Alexander, & Lillian Sung. (2012). Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia. PLoS ONE. 7(5). e38300–e38300. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026